Your browser doesn't support javascript.
loading
TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer.
Wei, Zimeng; Zeng, Xingruo; Lei, Yufei; He, Hengjing; Jamal, Muhammad; Zhang, Chengjie; Tan, Haiyan; Xie, Songping; Zhang, Qiuping.
Afiliação
  • Wei Z; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • Zeng X; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • Lei Y; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • He H; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • Jamal M; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • Zhang C; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • Tan H; Gastrointestinal Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xie S; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Zhang Q; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University, Wuhan, China. Electronic address: qpzhang@whu.edu.cn.
Int Immunopharmacol ; 110: 108999, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35858518

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article